Trademark: PRECISION PHENOTYPE 2246506
Word
PRECISION PHENOTYPE
ID
2246506
Trademark Type
Word
Status
Not protected: Not accepted
Application Date
25 May 2021
Owner(s)
Service
Ashurst Australia
Goods and Services:
Class 5:
Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders.
Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders.
Class 42:
Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; scientific research, namely, analyzing genetic, genomic, biological and clinical data; scientific research, namely, analyzing genetic, genomic, biological and clinical data for research and development relating to the treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.
Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; scientific research, namely, analyzing genetic, genomic, biological and clinical data; scientific research, namely, analyzing genetic, genomic, biological and clinical data for research and development relating to the treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.
Class 44:
Medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data; medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data for the development and treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.
Medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data; medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data for the development and treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.